The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield, CEO of Glass Pharms. Tim & James discuss the challenges and progress within the UK's medical cannabis industry since its legalisation in 2018, highlighting the previous stagnation due to various factors including inconsistent supply chains and a lack of a healthcare-focused approach. The discussion emphasises the importance of quality, consistency, and patient outcomes, showcasing how their collaboration aims to provide reliable medical cannabis to patients. They also touch upon the regulatory landscape, the need for better education for doctors, and the potential for significant growth in the UK market by addressing unmet healthcare needs.

This episode was recorded live at Cannabis Europa, 2024.

Next up we have a special episode with Tim Kirby, Chief Executive Officer with Releaf and Michael Sassano, CEO and Chairman of the Board with SOMAÍ Pharmaceuticals.

This episode was recorded live at Cannabis Europa, 2024.

This podcast was recorded live at Cannabis Europa 2024.

This podcast was recorded live at Cannabis Europa 2024.

This podcast was recorded live at Cannabis Europa 2024.

This podcast was recorded live at Cannabis Europa 2024.

This podcast was recorded live at Cannabis Europa 2024.

This podcast was recorded live at Cannabis Europa 2024.

Recorded live at the Barbican Centre, June 2024.

This podcast was recorded live at Cannabis Europa, 2024.

Recorded live at the Barbican Centre, June 2024.

This podcast was recorded live at Cannabis Europa, 2024.

Recorded live at the Barbican Centre, June 2024.

Next up is episode 3, with CEO of Project Evolve and Co-Founder of the GCNC Chris Day. Chris is the co-founder of the Global Cannabis Network Collective and CEO of Project Evolve, with over 25 years of experience in corporate reinvention, small business growth, and marketing excellence. Join us as our host Shahbaaz Kara-Virani chats with Chris about some of the issues the GCNC is tackling today. Business of Cannabis is a cannabis industry platform marrying cannabis news, video and podcast content, newsletters and online and real-world cannabis events. This channel highlights the cannabis companies, cannabis brands, cannabis leaders and cannabis trends driving the global sector. www.businessofcannabis.com Twitter: www.twitter.com/bofc_global / www.twitter.com/bofc_europe LinkedIn: www.linkedin.com/company/businessofcannabis Instagram: www.instagram.com/businessofcannabis Facebook: www.facebook.com/bofcmedia Apple: http://bofc.me/applepod Podcasts Online: https://bofc.me/bofclive

This fireside discussion offers a deep dive into the expansion plans and business objectives for Curaleaf International; their strategies for entering new global markets, potential regulatory challenges, and how they plan to leverage their position as a leading cannabis company. Join us at Cannabis Europa 2025 www.cannabis-europa.com Keep up to date with the company's vision for global growth, potential partnerships, and innovations in product offerings. Join us for a fireside chat with Curaleaf Executive Chairman, Boris Jordan and Omar Sacirbey, Editor at MJBiz Magazine.

Episode 2 is here, and this time Luc Richner joins Shahbaaz in the hot seat to chat about his journey, Switzerland and sustainable cannabis business models in the future. If you don't know Luc, he's the CEO and co-founder of Vigia, the company behind the compliance software suite Cannavigia. With over 12 years of experience in building and managing companies across various industries in Europe, the Middle East, and Southeast Asia, it's fair to say he's an accomplished entrepreneur.

This quarter two seismic shifts occurred in the United States and Germany with a common denominator: the DEA advanced the rescheduling of cannabis from a narcotic to a Class III drug in the USA, and Germany completed the rescheduling with passage of the Cannabis Reform Law April 1. However, the implications are different for the two largest cannabis markets. Join us for a fireside chat with Arthur de Cordova, a former Country Manager for AstraZeneca in Europe, and CEO of Ziel.